CTCF
Transcriptional repressor CTCF
Also known as: CFAP108, CTCF_HUMAN, FAP108
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49711
- Gene
- CTCF
- Ensembl
- ENSG00000102974
- Chromosome
- 16
- Canonical length
- 727 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene is a member of the BORIS + CTCF gene family and encodes a transcriptional regulator protein with 11 highly conserved zinc finger (ZF) domains. This nuclear protein is able to use different combinations of the ZF domains to bind different DNA target sequences and proteins. Depending upon the context of the site, the protein can bind a histone acetyltransferase (HAT)-containing complex and function as a transcriptional activator or bind a histone deacetylase (HDAC)-containing complex and function as a transcriptional repressor. If the protein is bound to a transcriptional insulator element, it can block communication between enhancers and upstream promoters, thereby regulating imprinted expression. Mutations in this gene have been associated with invasive breast cancers, prostate cancers, and Wilms' tumors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
727 residues, UniProt reviewed canonical sequence.
>P49711|CTCF
1 MEGDAVEAIV EESETFIKGK ERKTYQRRRE GGQEEDACHL PQNQTDGGEV VQDVNSSVQM
61 VMMEQLDPTL LQMKTEVMEG TVAPEAEAAV DDTQIITLQV VNMEEQPINI GELQLVQVPV
121 PVTVPVATTS VEELQGAYEN EVSKEGLAES EPMICHTLPL PEGFQVVKVG ANGEVETLEQ
181 GELPPQEDPS WQKDPDYQPP AKKTKKTKKS KLRYTEEGKD VDVSVYDFEE EQQEGLLSEV
241 NAEKVVGNMK PPKPTKIKKK GVKKTFQCEL CSYTCPRRSN LDRHMKSHTD ERPHKCHLCG
301 RAFRTVTLLR NHLNTHTGTR PHKCPDCDMA FVTSGELVRH RRYKHTHEKP FKCSMCDYAS
361 VEVSKLKRHI RSHTGERPFQ CSLCSYASRD TYKLKRHMRT HSGEKPYECY ICHARFTQSG
421 TMKMHILQKH TENVAKFHCP HCDTVIARKS DLGVHLRKQH SYIEQGKKCR YCDAVFHERY
481 ALIQHQKSHK NEKRFKCDQC DYACRQERHM IMHKRTHTGE KPYACSHCDK TFRQKQLLDM
541 HFKRYHDPNF VPAAFVCSKC GKTFTRRNTM ARHADNCAGP DGVEGENGGE TKKSKRGRKR
601 KMRSKKEDSS DSENAEPDLD DNEDEEEPAV EIEPEPEPQP VTPAPPPAKK RRGRPPGRTN
661 QPKQNQPTAI IQVEDQNTGA IENIIVEVKK EPDAEPAEGE EEEAQPAATD APNGDLTPEM
721 ILSMMDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTCF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- thymus: 65 nTPM
- tonsil: 33 nTPM
- bone marrow: 33 nTPM
- skeletal muscle: 29 nTPM
- lymph node: 27 nTPM
- parathyroid gland: 27 nTPM
Single-cell type
- erythrocyte progenitors: 206 nCPM
- monocyte progenitors: 189 nCPM
- neutrophil progenitors: 133 nCPM
- megakaryocyte progenitors: 125 nCPM
- neutrophils: 104 nCPM
- myonuclei: 98 nCPM
Immune cell
- naive B-cell: 7.4 nTPM
- basophil: 6.8 nTPM
- neutrophil: 6.8 nTPM
- memory B-cell: 5.6 nTPM
- plasmacytoid DC: 5.6 nTPM
- memory CD4 T-cell: 4.8 nTPM
Brain region
- cerebellum: 49 nTPM
- white matter: 44 nTPM
- cerebral cortex: 39 nTPM
- basal ganglia: 37 nTPM
- hypothalamus: 37 nTPM
- hippocampal formation: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTCF.
Disease | AllUniProt
Conditions CTCF is implicated in, by any mechanism.
- Intellectual developmental disorder, autosomal dominant 21 (MRD21) MIM:615502
Disease | GeneticClinVar
95 pathogenic / likely-pathogenic of 392 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- CTCF-related neurodevelopmental disorder
- Inborn genetic diseases
- CTCF-related disorder
- Intellectual disability
- Melanoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.44
- DepMap mean gene effect
- -1.63
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle cell development
- chromatin looping
- chromosome segregation
- DNA methylation-dependent constitutive heterochromatin formation
- epigenetic regulation of gene expression
- gene expression
- genomic imprinting
- in utero embryonic development
- mitochondrion organization
- negative regulation of cell population proliferation
- negative regulation of DNA-templated transcription
- negative regulation of gene expression via chromosomal CpG island methylation
- negative regulation of transcription by RNA polymerase II
- positive regulation of DNA-templated transcription
- positive regulation of gene expression
- positive regulation of transcription by RNA polymerase II
- protein localization to chromosome, centromeric region
- regulation of centromeric sister chromatid cohesion
- regulation of transcription by RNA polymerase II
Molecular functions
- chromatin insulator sequence binding
- DNA-binding transcription factor activity
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- transcription cis-regulatory region binding
- transcription coregulator binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTCF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTCF as an antibody target. Whether an autoantibody or antibody against CTCF could matter depends on whether native CTCF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTCF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTCF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...